Where does Indapta Therapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Indapta Therapeutics's 4 recorded funding rounds.

Premier Alternatives

Indapta Therapeutics

Drug Discovery · Houston, TX · Founded 2017 · Privately Held (backing)

Operator of a biotechnology company focused on developing a natural killer cell therapy with potent activity to treat cancer. Indapta Therapeutics is based in Houston, TX and was founded in 2017. Its last reported valuation was $90 million in May 2023. It has raised $162 million across 4 recorded rounds; the latest was a $50.8 million later-stage round in Sep 2025.

Last reported valuation

$90.0M

Oct 2026

Priced at

—

Total raised

$162.3M

Last round

Later Stage VC

Sep 2025

Cap table — not yet on record

Indapta Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Indapta Therapeutics with a free account

·The complete investor list: 11 names
·Watch Indapta Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Indapta Therapeutics

Where does Indapta Therapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Indapta Therapeutics's 4 recorded funding rounds.